The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling.

Article Details


Anjum R, Roux PP, Ballif BA, Gygi SP, Blenis J

The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling.

Curr Biol. 2005 Oct 11;15(19):1762-7.

PubMed ID
16213824 [ View in PubMed

The viability of vertebrate cells depends on a complex signaling interplay between survival factors and cell-death effectors. Subtle changes in the equilibrium between these regulators can result in abnormal cell proliferation or cell death, leading to various pathological manifestations. Death-associated protein kinase (DAPK) is a multidomain calcium/calmodulin (CaM)-dependent Ser/Thr protein kinase with an important role in apoptosis regulation and tumor suppression. The molecular signaling mechanisms regulating this kinase, however, remain unclear. Here, we show that DAPK is phosphorylated upon activation of the Ras-extracellular signal-regulated kinase (ERK) pathway. This correlates with the suppression of the apoptotic activity of DAPK. We demonstrate that DAPK is a novel target of p90 ribosomal S6 kinases (RSK) 1 and 2, downstream effectors of ERK1/2. Using mass spectrometry, we identified Ser-289 as a novel phosphorylation site in DAPK, which is regulated by RSK. Mutation of Ser-289 to alanine results in a DAPK mutant with enhanced apoptotic activity, whereas the phosphomimetic mutation (Ser289Glu) attenuates its apoptotic activity. Our results suggest that RSK-mediated phosphorylation of DAPK is a unique mechanism for suppressing the proapoptotic function of this death kinase in healthy cells as well as Ras/Raf-transformed cells.

DrugBank Data that Cites this Article

NameUniProt ID
Death-associated protein kinase 1P53355Details
Ribosomal protein S6 kinase alpha-1Q15418Details
Ribosomal protein S6 kinase alpha-3P51812Details